Drug Pipeline

Ropivacaine 0.5% Injectable Solution Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
5
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07616882 Comparison of Hemodynamic Effects of Bupivacaine in Spinal Anesthesia Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 4
3
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07180979 PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty Hip Osteoarthritis Recruiting
NCT07334132 General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient… Osteo Arthritis Knee and Hip Not Yet Recruiting
NCT07216586 Zynrelef Versus Adductor Canal Block Knee Osteoarthritis Not Yet Recruiting
Phase 2
NCT07616882 Comparison of Hemodynamic Effects of Bupivacaine in Spinal Anesthesia Hemondynamic Changes in Spinal Anesthesia Not Yet Recruiting
Not specified
NCT05024344 ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy Nephrolithotomy, Percutaneous Recruiting
Sponsors Running Ropivacaine 0.5% Injectable Solution Trials
University of Tennessee Medical Center (1) Poznan University of Medical Sciences (1) University of Miami (1) Region Örebro County (1) Liaquat National Hospital & Medical College (1)
Get alerts when Ropivacaine 0.5% Injectable Solution trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free